What are Indivior Pharmaceuticals, Inc. 's profit margins?

Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.

Where do Indivior Pharmaceuticals, Inc. 's ratios come from?

Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Indivior Pharmaceuticals, Inc. INDV Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	81.3%+1.1pp	80.2%-0.6pp	80.8%-1.3pp	82.1%+2.4pp	79.8%-0.8pp
Operating margin	25.8%+4.7pp	21.1%+1.9pp	19.2%+0.6pp	18.7%+16.2pp	2.5%-0.7pp
Net margin	19.4%+2.6pp	16.9%+6.0pp	10.8%+1.6pp	9.2%+9.8pp	-0.6%-1.2pp
EBITDA margin	26.5%+4.6pp	21.9%+1.6pp	20.3%+0.5pp	19.8%+16.2pp	3.7%-0.9pp
Free cash flow margin	-14.9%-7.4pp	-7.5%—	——	——	——
Returns
Return on assets	19.5%+2.9pp	16.6%—	——	——	——
Efficiency
Asset turnover	1×0.0×	1×—	——	——	——
Inventory turnover	37.2×-3.8×	41×-23.9×	64.9×+48.1×	16.8×+4.6×	12.2×+8.8×
Liquidity
Current ratio	0.9×+0.1×	0.7×-0.2×	1×+0.1×	0.9×0.0×	0.9×0.0×
Quick ratio	0.9×+0.1×	0.7×-0.2×	1×+0.1×	0.9×0.0×	0.9×0.0×
Cash ratio	0.2×0.0×	0.2×-0.2×	0.5×0.0×	0.5×+0.1×	0.4×0.0×
Leverage
Debt-to-assets	0.4×+0.1×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Net debt / EBITDA	1×+0.4×	0.6×+0.9×	-0.4×+0.2×	-0.6×-0.6×	-0×-1.1×
Interest coverage	8.3×+2.5×	5.8×+1.5×	4.4×+0.1×	4.3×+3.6×	0.6×-0.3×
Per Share
Book value per share	-$1.12-45.8%	-$0.77+52.3%	-$1.60+21.3%	-$2.04+10.5%	-$2.28+10.0%
Valuation
Market capitalization	$3.72B-17.2%	$4.49B+49.1%	$3.01B+73.2%	$1.74B+46.2%	$1.19B-23.5%
Enterprise value	$4.05B-12.7%	$4.64B+59.0%	$2.92B+83.3%	$1.59B+34.3%	$1.19B-26.3%
Price / earnings	14.8×-6.7×	21.5×-2.0×	23.5×+7.4×	16.1×—	——
Price / sales	2.9×-0.7×	3.6×+1.1×	2.5×+1.1×	1.5×+0.5×	1×-0.3×
EV / EBITDA	11.8×-5.2×	17.1×+4.9×	12.2×+5.3×	6.8×-20.7×	27.6×-2.2×
EV / sales	3.1×-0.6×	3.7×+1.3×	2.5×+1.1×	1.4×+0.3×	1×-0.3×
Free cash flow yield	-5.2%-3.1pp	-2.1%—	——	——	——
Earnings yield	6.8%+2.1pp	4.7%+0.4pp	4.3%-2.0pp	6.2%+6.8pp	-0.6%-1.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Indivior Pharmaceuticals, Inc. 's profit margins?: Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.
Where do Indivior Pharmaceuticals, Inc. 's ratios come from?: Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.